Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Assets Average (2016 - 2025)

Standard Biotools (LAB) has disclosed Assets Average for 15 consecutive years, with $548.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets Average fell 21.12% to $548.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $548.3 million, a 21.12% decrease, with the full-year FY2024 number at $467.7 million, up 31.12% from a year prior.
  • Assets Average was $548.3 million for Q3 2025 at Standard Biotools, down from $568.3 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $743.2 million in Q2 2024 to a low of $273.6 million in Q1 2022.
  • A 5-year average of $442.6 million and a median of $381.0 million in 2023 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: surged 104.32% in 2024, then dropped 23.54% in 2025.
  • Standard Biotools' Assets Average stood at $278.7 million in 2021, then soared by 44.46% to $402.6 million in 2022, then dropped by 17.74% to $331.2 million in 2023, then soared by 95.35% to $646.9 million in 2024, then decreased by 15.25% to $548.3 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Assets Average are $548.3 million (Q3 2025), $568.3 million (Q2 2025), and $596.0 million (Q1 2025).